| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |